Abstracts tagged "Adipocytokines and rheumatoid arthritis (RA)"

Abstract Number: 2410 • 2013 ACR/ARHP Annual Meeting
Effects Of Leptin and Adiponectin On Proliferation and Activation Were Are Significantly Increased In CD4⁺ T Cells From Rheumatoid Arthritis Patients
Daniel Xibille-Friedmann¹, Carolina Bustos-Rivera Bahena², Marisol Sandoval-Rios³ and Jose Luis Montiel-Hernandez³, ¹Rheumatology, Hospital General de Cuernavaca, Cuernavaca, Mexico, ²Universidad Autonoma del Estado de Morelos, Facultad de Ciencias, Cuernavaca, Mexico, ³Universidad Autonoma del Estado de Morelos, Facultad de Farmacia, Cuernavaca, Mexico
Background/Purpose: In vitro and in vivo studies suggest that leptin and adiponectin are involved in the development of inflammation in RA patients. Previous findings by…
Abstract Number: 950 • 2013 ACR/ARHP Annual Meeting
Changes In Circulating Visfatin Levels By Different Anti-Rheumatic Treatments: A Comparison Among Synthetic Disease Modifying Anti-Rheumatic Drugs, Tumor Necrosis Factor Blockade and B-Cell Depletion For Rheumatoid Arthritis
Hana Hulejová¹, Markéta Kuklová², Herman F. Mann³, Mária Filková⁴, Olga Kryštufková⁵, Karel Pavelka⁶, Ondrej Sglunda⁷, Jiri Vencovsky⁸ and Ladislav Senolt⁸, ¹Department of Clinical and Experimental Rheumatology, 1st Faculty of Medicine, Charles University, Institute of Rheumatology, Prague, Czech Republic, ²Institute of Rheumatology, Department of Experimental Rheumatology, 1st Faculty of Medicine, Charles University in Prague, Prague, Czech Republic, ³Institute of Rheumatology and Department of Rheumatology, 1st Faculty of Medicine, Charles University, Prague, Prague, Czech Republic, ⁴Institute of Rheumatology and Department of Rheumatology, 1st Faculty of Medicine, Charles University in Prague, Prague, Czech Republic, ⁵Institute of Rheumatology, and Dept. of Rheumatology, 1st Faculty of Medicine, Charles University, Prague, Czech Republic, Prague, Czech Republic, ⁶Department of Clinical and Experimental Rheumatology, Charles University, Prague, Czech Republic, ⁷Institute of Rheumatology and Department of Rheumatology of the First Faculty of Medicine, Charles University in Prague, Czech Republic, Prague, Czech Republic, ⁸Department of Clinical and Experimental Rheumatology, 1st Faculty of Medicine, Charles University, Prague, Institute of Rheumatology, Prague, Czech Republic
Background/Purpose: Visfatin is an insulin mimetic adipokine that has been originally described as a pre-B cell colony-enhancing factor. Association between elevated visfatin levels, disease activity…
Abstract Number: 443 • 2012 ACR/ARHP Annual Meeting
Secreted Frizzled-Related Protein 5 Exerts the Anti-Inflammatory Role in Rheumatoid Arthritis Via Down-Regulation of c-Jun N-Terminal Kinase
Yong-Jin Kwon¹, Tae-Yeon Kim², Sang-Won Lee³, Yong-Beom Park³, Soo Kon Lee⁴ and Min-Chan Park¹, ¹Department of Internal Medicine, Yonse University College of Medicine, Seoul, South Korea, ²Dept. of Internal Medicine, Yonse University College of Medicine, Seoul, South Korea, ³Department of Internal Medicine, Yonsei University College of Medicine, Seoul, South Korea, ⁴Internal Medicine, Yonsei University College of Medicine, Seoul, South Korea
Background/Purpose: Secreted frizzled-related protein 5 (Sfrp5) is a novel adipokine that has beneficial effects on metabolic dysfunction by controlling inflammatory cells within adipose tissue. Sfrp5…
Abstract Number: 2122 • 2012 ACR/ARHP Annual Meeting
Plasma chemerin as a Useful Marker for Disease Activity in Patients with Rheumatoid Arthritis
Sang Tae Choi¹, You-Jung HA², Eun-Jin Kang³, Kwang-Hoon Lee⁴ and Jung-Soo Song¹, ¹Rheumatology, Chung-Ang University College of Medicine, Seoul, South Korea, ²Division of Rheumatology, Department of Internal Medicine, Kwanding University College of Medicine, Myongji Hospital, Goyang, South Korea, ³Rheumatology, Busan Medical Center, Busan, South Korea, ⁴Dongguk University Ilsan Hospital, Goyang, South Korea
Background/Purpose: Chemerin is an adipokine that is linked to adipogenesis and chemotaxis of the innate immune system. It is expressed on macrophage, dendritic cells, and…

All abstracts accepted to ACR Convergence are under embargo once the ACR has notified presenters of their abstract’s acceptance, and cannot be presented at other meetings after this time. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. Academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part a scientific presentation or presentation of additional new information that will be available at the time of the meeting) is under embargo until November 7 at 10:00 AM ET. Journalists with access to embargoed information also cannot release articles before this time.

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Permissions and Reprints

For information about abstract permissions and reprints, see ACR Convergence permissions and reprint policies.